AN ACT CONCERNING DRUGS PRESCRIBED TO TREAT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.
This bill requires pharmacists to obtain a quantitative electroencephalogram (qEEG) brain wave test - produced specifically for the patient - before dispensing medication for attention-deficit/hyperactivity disorder (ADHD), in addition to verifying a valid prescription. It directly affects patients seeking ADHD medication and pharmacists who must comply with this new requirement. The law amends pharmacy regulations to mandate this brain wave test as a condition for dispensing these drugs. This policy change specifically alters the dispensing process for ADHD medications under state law.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 8, 2025
Last action Jan 8, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
1
Jan 8, 2025
Committee
REF. TO JOINT COMM. ON General Law
upper
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 150
Scope: CT
Hi! I can help you understand SB 150. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline